Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
June 28, 2024 - The Dermatology Digest
Subscribe
Search

Day: June 28, 2024

AD Pipeline Watch: Lebrikizumab Improves Quality of Life in AD Patients

Lebrikizumab monotherapy improves quality of life (QoL) and mental health for patients with moderate-to-severe atopic dermatitis (AD), according to new data from ADvocate1 and ADvocate2 in Dermatology and Therapy. Lebrikizumab is a targeted interleukin (IL)-13 inhibitor under investigation in the U.S with a decision from the Food and Drug Administration (FDA) expected in the second half of […]